Diagnosis delay in Libyan female breast cancer

BMC Research Notes

Yrjö Collan¹  Seppo Pyrhönen²  Entesar Larbesh⁶  Abdelbaset Buhmeida⁵  Fathi Abdalla³  Eramah Ermiah⁴ 

[1] Department of Pathology, Turku University Hospital, Turku, Finland;Department of Oncology, University of Turku, Turku, Finland;Department of Pathology, Misurata Cancer Institute, Misurata, Libya;Department of Oncology, National Oncology Institute, Sabratha, Libya;Center of Excellence in Genomic Medicine Research, King Abdul-Aziz University, Jeddah, Saudi Arabia;Department of Pathology, National Oncology Institute, Sabratha, Libya

关键词: Diagnosis delay;    Libyan female breast cancer;   

Others  :  1165904
DOI  :  10.1186/1756-0500-5-452

 received in 2012-05-25, accepted in 2012-08-10,  发布年份 2012

【 摘 要 】

Aims

To study the diagnosis delay and its impact on stage of disease among women with breast cancer on Libya.

Methods

200 women, aged 22 to 75 years with breast cancer diagnosed during 2008–2009 were interviewed about the period from the first symptoms to the final histological diagnosis of breast cancer. This period (diagnosis time) was categorized into 3 periods: <3 months, 3–6 months, and >6 months. If diagnosis time was longer than 3 months, the diagnosis was considered delayed (diagnosis delay). Consultation time was the time taken to visit the general practitioner after the first symptoms. Retrospective preclinical and clinical data were collected on a form (questionnaire) during an interview with each patient and from medical records.

Results

The median of diagnosis time was 7.5 months. Only 30.0% of patients were diagnosed within 3 months after symptoms. 14% of patients were diagnosed within 3–6 months and 56% within a period longer than 6 months. A number of factors predicted diagnosis delay: Symptoms were not considered serious in 27% of patients. Alternative therapy (therapy not associated with cancer) was applied in 13.0% of the patients. Fear and shame prevented the visit to the doctor in 10% and 4.5% of patients, respectively. Inappropriate reassurance that the lump was benign was an important reason for prolongation of the diagnosis time. Diagnosis delay was associated with initial breast symptom(s) that did not include a lump (p < 0.0001), with women who did not report monthly self examination (p < 0.0001), with old age (p = 0.004), with illiteracy (p = 0.009), with history of benign fibrocystic disease (p = 0.029) and with women who had used oral contraceptive pills longer than 5 years (p = 0.043). At the time of diagnosis, the clinical stage distribution was as follows: 9.0% stage I, 25.5% stage II, 54.0% stage III and 11.5% stage IV.

Diagnosis delay was associated with bigger tumour size (p <0.0001), with positive lymph nodes (N2, N3; p < 0.0001), with high incidence of late clinical stages (p < 0.0001), and with metastatic disease (p < 0.0001).

Conclusions

Diagnosis delay is very serious problem in Libya. Diagnosis delay was associated with complex interactions between several factors and with advanced stages. There is a need for improving breast cancer awareness and training of general practitioners to reduce breast cancer mortality by promoting early detection. The treatment guidelines should pay more attention to the early phases of breast cancer. Especially, guidelines for good practices in managing detectable of tumors are necessary.

【 授权许可】

   
2012 Ermiah et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Abussa A: Hospital cancer registry annual report 2006. Sabratha, Libya: African Oncology Institute; 2007:18-20.
• [2]El Mistiri M, Verdecchia A, Rashid I, El Sahli N, El Mangush M, Federico M: Cancer incidence in eastern Libya: the first report from the Benghazi Cancer Registry, 2003. Int J Cancer 2007, 120(2):392-397.
• [3]Najjar H, Easson A: Age at diagnosis of breast cancer in Arab nations. Int J Surg 2010, 8(6):448-452.
• [4]Montazeri A, Ebrahimi M, Mehrdad N, Ansari M, Sajadian A: Delayed presentation in breast cancer: a study in Iranian women. BMC Womens Health 2003, 3(1):4. BioMed Central Full Text
• [5]Chagpar AB, Crutcher CR, Cornwell LB, McMasters KM: Primary tumor size, not race, determines outcomes in women with hormone-responsive breast cancer. Surgery 2011, 150(4):796-801.
• [6]Kim J, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, et al.: Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes. Breast Cancer Res Treat 2012, 131(2):527-540.
• [7]Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA: Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999, 353(9159):1127-1131.
• [8]Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ: Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999, 353(9159):1119-1126.
• [9]Burgess CC, Ramirez AJ, Richards MA, Love SB: Who and what influences delayed presentation in breast cancer? Br J Cancer 1998, 77(8):1343-1348.
• [10]Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H: Patient delay and stage of diagnosis among breast cancer patients in Germany – a population based study. Br J Cancer 2002, 86(7):1034-1040.
• [11]Meechan G, Collins J, Petrie KJ: The relationship of symptoms and psychological factors to delay in seeking medical care for breast symptoms. Prev Med 2003, 36(3):374-378.
• [12]Velikova G, Booth L, Johnston C, Forman D, Selby P: Breast cancer outcomes in South Asian population of West Yorkshire. Br J Cancer 2004, 90(10):1926-1932.
• [13]Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK: Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 1992, 65(6):922-926.
• [14]Bish A, Ramirez A, Burgess C, Hunter M: Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res 2005, 58(4):321-326.
• [15]Jenner DC, Middleton A, Webb WM, Oommen R, Bates T: In-hospital delay in the diagnosis of breast cancer. Br J Surg 2000, 87(7):914-919.
• [16]Goodson WH 3rd, Moore DH 2nd: Causes of physician delay in the diagnosis of breast cancer. Arch Intern Med 2002, 162(12):1343-1348.
• [17]AJCC: AJCC Cancer Staging Manual. 5th edition. Lippincott: Lippincott- Raven; 1997.
• [18]Neal RD, Pasterfield D, Willkinson C, Hood K, Makin M, Lawrence H: Determining patient and primary care delay in the diagnosis of cancer - lessons from a pilot study of patients referred for suspected cancer. BMC Fam Pract 2008, 9:9. BioMed Central Full Text
• [19]Abulkhair O, Saghir N, Sedky L, Saadedin A, Elzahwary H, Siddiqui N, Al Saleh M, Geara F, Birido N, Al-Eissa N, et al.: Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. J Natl Compr Canc Netw 2010, 3(8 Suppl):S8-S15.
• [20]Stapleton JM, Mullan PB, Dey S, Hablas A, Gaafar R, Seifeldin IA, Banerjee M, Soliman AS: Patient-mediated factors predicting early- and late-stage presentation of breast cancer in Egypt. Psychooncology 2011, 20(5):532-537.
• [21]Montella M, Crispo A, D'Aiuto G, De Marco M, de Bellis G, Fabbrocini G, Pizzorusso M, Tamburini M, Silvestra P: Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev 2001, 10(1):53-59.
• [22]Andersen BL, Cacioppo JT: Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. The British journal of social psychology/the British Psychological Society 1995, 34(Pt 1):33-52.
• [23]Arndt V, Sturmer T, Stegmaier C, Ziegler H, Becker A, Brenner H: Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol 2003, 21(8):1440-1446.
• [24]Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, et al.: Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005, 16(4):655-663.
• [25]Ajekigbe AT: Fear of mastectomy: the most common factor responsible for late presentation of carcinoma of the breast in Nigeria. Clinical oncology (Royal College of Radiologists (Great Britain)) 1991, 3(2):78-80.
• [26]Norsa'adah B, Rampal KG, Rahmah MA, Naing NN, Biswal BM: Diagnosis delay of breast cancer and its associated factors in Malaysian women. BMC Cancer 2011, 11:141. BioMed Central Full Text
• [27]Andersen RS, Vedsted P, Olesen F, Bro F, Sondergaard J: Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res 2009, 9:189. BioMed Central Full Text
• [28]Grunfeld EA, Hunter MS, Ramirez AJ, Richards MA: Perceptions of breast cancer across the lifespan. J Psychosom Res 2003, 54(2):141-146.
• [29]Jones R, Latinovic R, Charlton J, Gulliford MC: Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007, 334(7602):1040.
• [30]Weiss NS: Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J 2003, 9(Suppl 2):S86-89.
• [31]Huguley CM Jr, Brown RL, Greenberg RS, Clark WS: Breast self-examination and survival from breast cancer. Cancer 1988, 62(7):1389-1396.
• [32]Facione NC: Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med 1993, 36(12):1521-1534.
• [33]Grunfeld EA, Ramirez AJ, Hunter MS, Richards MA: Women's knowledge and beliefs regarding breast cancer. Br J Cancer 2002, 86(9):1373-1378.
• [34]Montella M, Crispo A, Botti G, De Marco M, de Bellis G, Fabbrocini G, Pizzorusso M, Tamburini M, D'Aiuto G: An assessment of delays in obtaining definitive breast cancer treatment in Southern Italy. Breast Cancer Res Treat 2001, 66(3):209-215.